Thor Medical ASA
OSE:TRMED

Watchlist Manager

Thor Medical ASA

OSE:TRMED

Watchlist

Dividends

Discount Rate

Price: 2.835 NOK 10.74% Market Closed

Market Cap: 665.8m NOK

Have any thoughts about
Thor Medical ASA?

Write Note

Write Note Create Alert Ask AI

Add Note Why Create Notes?

Capture your thoughts

Note Buy Sell Hold Pass

US	Johnson & Johnson NYSE:JNJ	Pharmaceuticals
US	Berkshire Hathaway Inc NYSE:BRK.A	Financial Services
US	Bank of America Corp NYSE:BAC	Banking
US	Mastercard Inc NYSE:MA	Technology
US	UnitedHealth Group Inc NYSE:UNH	Health Care
US	Exxon Mobil Corp NYSE:XOM	Energy
US	Pfizer Inc NYSE:PFE	Pharmaceuticals
US	Palantir Technologies Inc NYSE:PLTR	Technology
US	Nike Inc NYSE:NKE	Textiles, Apparel & Luxury Goods
US	Visa Inc NYSE:V	Technology
CN	Alibaba Group Holding Ltd NYSE:BABA	Retail
US	3M Co NYSE:MMM	Industrial Conglomerates
US	JPMorgan Chase & Co NYSE:JPM	Banking
US	Coca-Cola Co NYSE:KO	Beverages
US	Walmart Inc NYSE:WMT	Retail
US	Verizon Communications Inc NYSE:VZ	Telecommunication

Add Price Alert

Price Target:

Last Price: 2.835 NOK

We'll email you a reminder when the closing price reaches USD.

If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.

Peter Lynch

Track and Analyze Performance

Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.

Continuous Learning and Adaptation

Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.

Boost Decision Confidence

With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.

Why create notes?

Back

Delete Note

Do you really want to delete this note?
This action cannot be undone.

Remove price alert for reaching

Delete

Cancel

TRMED Alert

Thor Medical ASA

2.835

+0.275 (+10.74%)

52 Week Range	0.884 4.195
Price Target

We'll email you a reminder when the closing price reaches NOK.

Save Alert

Choose the stock you wish to monitor with a price alert.

	Johnson & Johnson NYSE:JNJ	US
	Berkshire Hathaway Inc NYSE:BRK.A	US
	Bank of America Corp NYSE:BAC	US
	Mastercard Inc NYSE:MA	US
	UnitedHealth Group Inc NYSE:UNH	US
	Exxon Mobil Corp NYSE:XOM	US
	Pfizer Inc NYSE:PFE	US
	Palantir Technologies Inc NYSE:PLTR	US
	Nike Inc NYSE:NKE	US
	Visa Inc NYSE:V	US
	Alibaba Group Holding Ltd NYSE:BABA	CN
	3M Co NYSE:MMM	US
	JPMorgan Chase & Co NYSE:JPM	US
	Coca-Cola Co NYSE:KO	US
	Walmart Inc NYSE:WMT	US
	Verizon Communications Inc NYSE:VZ	US

Delete Alert

This alert will be permanently deleted.

Remove note

Delete

Cancel

Ask me anything about

Thor Medical ASA

What unique competitive advantages
does Thor Medical ASA hold over its rivals?

What risks and challenges
does Thor Medical ASA face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Provide an overview of the primary business activities
of Thor Medical ASA.

What unique competitive advantages
does Thor Medical ASA hold over its rivals?

What risks and challenges
does Thor Medical ASA face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Thor Medical ASA.

Provide P/S
for Thor Medical ASA.

Provide P/E
for Thor Medical ASA.

Provide P/OCF
for Thor Medical ASA.

Provide P/FCFE
for Thor Medical ASA.

Provide P/B
for Thor Medical ASA.

Provide EV/S
for Thor Medical ASA.

Provide EV/GP
for Thor Medical ASA.

Provide EV/EBITDA
for Thor Medical ASA.

Provide EV/EBIT
for Thor Medical ASA.

Provide EV/OCF
for Thor Medical ASA.

Provide EV/FCFF
for Thor Medical ASA.

Provide EV/IC
for Thor Medical ASA.

What are the Revenue projections
for Thor Medical ASA?

How accurate were the past Revenue estimates
for Thor Medical ASA?

What are the Net Income projections
for Thor Medical ASA?

How accurate were the past Net Income estimates
for Thor Medical ASA?

What are the EPS projections
for Thor Medical ASA?

How accurate were the past EPS estimates
for Thor Medical ASA?

What are the EBIT projections
for Thor Medical ASA?

How accurate were the past EBIT estimates
for Thor Medical ASA?

Compare the revenue forecasts
for Thor Medical ASA with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Thor Medical ASA and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Thor Medical ASA against its competitors.

Analyze the profit margins
(gross, operating, and net) of Thor Medical ASA compared to its peers.

Compare the P/E ratios
of Thor Medical ASA against its peers.

Discuss the investment returns and shareholder value creation
comparing Thor Medical ASA with its peers.

Analyze the financial leverage
of Thor Medical ASA compared to its main competitors.

Show all profitability ratios
for Thor Medical ASA.

Provide ROE
for Thor Medical ASA.

Provide ROA
for Thor Medical ASA.

Provide ROIC
for Thor Medical ASA.

Provide ROCE
for Thor Medical ASA.

Provide Gross Margin
for Thor Medical ASA.

Provide Operating Margin
for Thor Medical ASA.

Provide Net Margin
for Thor Medical ASA.

Provide FCF Margin
for Thor Medical ASA.

Show all solvency ratios
for Thor Medical ASA.

Provide D/E Ratio
for Thor Medical ASA.

Provide D/A Ratio
for Thor Medical ASA.

Provide Interest Coverage Ratio
for Thor Medical ASA.

Provide Altman Z-Score Ratio
for Thor Medical ASA.

Provide Quick Ratio
for Thor Medical ASA.

Provide Current Ratio
for Thor Medical ASA.

Provide Cash Ratio
for Thor Medical ASA.

What is the historical Revenue growth
over the last 5 years for Thor Medical ASA?

What is the historical Net Income growth
over the last 5 years for Thor Medical ASA?

What is the current Free Cash Flow
of Thor Medical ASA?

Discuss the annual earnings per share (EPS)
trend over the past five years for Thor Medical ASA.

EV/EBITDA
Enterprise Value to EBITDA

-32.7

Current

-2.1

Median

4.2

Industry

Lower than median

Lower than industry value

Enterprise Value to EBITDA (EV/EBITDA) ratio is a valuation multiple that compares the value of a company, debt included, to the company’s cash earnings less non-cash expenses. EBITDA can be misleading at times, especially for companies that are highly capital intensive.

EV/EBITDA

-32.7

Enterprise Value

737.7m NOK

EBITDA

-19.4m NOK

All Countries

Forward Multiples

			Market Cap	EV/EBITDA
NO	T	Thor Medical ASA OSE:TRMED	665.8m NOK	-32.7
FR		Pharnext SCA OTC:PNEXF	6T USD	-218 147.8
US		Abbvie Inc NYSE:ABBV	325.5B USD	15.8
US		Amgen Inc NASDAQ:AMGN	150.4B USD	16.8
US		Vertex Pharmaceuticals Inc NASDAQ:VRTX	120.9B USD	25.1
US		Gilead Sciences Inc NASDAQ:GILD	115.7B USD	10.2
US	E	Epizyme Inc F:EPE	94.1B EUR	-517.9
AU		CSL Ltd ASX:CSL	135.7B AUD	20.5
US		Regeneron Pharmaceuticals Inc NASDAQ:REGN	83.7B USD	16.4
US	S	Seagen Inc F:SGT	39.3B EUR	-59.2
NL		argenx SE XBRU:ARGX	34.6B EUR	-105.5

				EBITDA Growth
NO	T	Thor Medical ASA OSE:TRMED	Average EV/EBITDA: 17.5 Negative Multiple: -32.7	N/A
FR		Pharnext SCA OTC:PNEXF	Negative Multiple: -218 147.8	N/A
US		Abbvie Inc NYSE:ABBV	15.8	29%
US		Amgen Inc NASDAQ:AMGN	16.8	62%
US		Vertex Pharmaceuticals Inc NASDAQ:VRTX	25.1	43%
US		Gilead Sciences Inc NASDAQ:GILD	10.2	16%
US	E	Epizyme Inc F:EPE	Negative Multiple: -517.9	N/A
AU		CSL Ltd ASX:CSL	20.5	42%
US		Regeneron Pharmaceuticals Inc NASDAQ:REGN	16.4	35%
US	S	Seagen Inc F:SGT	Negative Multiple: -59.2	N/A
NL		argenx SE XBRU:ARGX	Negative Multiple: -105.5	N/A

EV/EBITDA Forward Multiples

Forward EV/EBITDA multiple is a version of the EV/EBITDA ratio that uses forecasted EBITDA for the EV/EBITDA calculation. 1-Year, 2-Years, and 3-Years forwards use EBITDA forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward

EV/EBITDA

-11.9

2-Years Forward

EV/EBITDA

N/A

3-Years Forward

EV/EBITDA

N/A

Thor Medical ASA
OSE:TRMED

EV/EBITDA
Enterprise Value to EBITDA

EV/EBITDA Forward Multiples

See Also

Company

Help

Tools

Stocks

Thor Medical ASA OSE:TRMED

EV/EBITDA Enterprise Value to EBITDA

EV/EBITDA Forward Multiples

See Also

Company

Help

Tools

Stocks

Thor Medical ASA
OSE:TRMED

EV/EBITDA
Enterprise Value to EBITDA